Actively Recruiting
Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases
Led by Laval University · Updated on 2024-06-07
82
Participants Needed
3
Research Sites
99 weeks
Total Duration
On this page
Sponsors
L
Laval University
Lead Sponsor
I
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this validation study is to provide further evidence of the metrological properties of the 6-minute stepper test in individuals with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD). The main questions it aims to answer are: 1. Is the 6-minute stepper test valid when compared to the 6-minute walk test and a maximal cardiopulmonary cycling test? 2. Does the 6-minute stepper test give the same results when conducted through direct (i.e., therapist in person) and remote (i.e., videoconferencing) monitoring? 3. Is the 6-minute stepper test safe when conducted at the home of the individual with direct (i.e., therapist in person) or remote (i.e., videoconferencing) monitoring? Participants will: * Conduct the 6-minute stepper test (several trials on separate days) * Conduct the 6-minute walk test (1 trial on 1 day) * Conduct a maximal cardiopulmonary test on a cycle ergometer (1 trial on 1 day) * Participate in a semi-structured interview to provide their feedback with regards to the 6-minute stepper test
CONDITIONS
Official Title
Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 40 years or older
- Diagnosis of chronic obstructive pulmonary disease (GOLD 2 to 4) or interstitial lung disease for more than 6 months
- Clinically stable for at least 4 weeks
You will not qualify if you...
- Interstitial lung disease linked to connective tissue disease or sarcoidosis
- Unstable or severe heart conditions
- Rheumatologic or neurologic conditions that cause disability
- Weight above the exercise equipment limit (e.g., over 130 kg for the stepper)
- Any physical condition that limits or prevents exercise testing
- Participation in another study requiring medication changes
- Pulmonary rehabilitation within the past year
- Use of oxygen therapy for arm 1 participants (due to inability to perform gas analysis)
- Participation in arm 1 for arm 2 participants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval
Québec, Canada, G1V 4G5
Actively Recruiting
2
Groupement des Hôpitaux de l'Institut Catholique de Lille
Lille, Hauts-de-France, France, 59000
Actively Recruiting
3
FormAction Santé
Pérenchies, Hauts-de-France, France, 59840
Not Yet Recruiting
Research Team
A
Alec Bass, PT, PhD
CONTACT
M
Marianne Belley
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here